| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/27/2009 | CA2332038C Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 01/27/2009 | CA2322633C An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 01/27/2009 | CA2265198C Method of producing a nicotine medicament and a medicament made by the method |
| 01/27/2009 | CA2264028C A stable ointment containing acetyl salicylic acid |
| 01/27/2009 | CA2191951C Monoamine, diamide, thiol-containing metal chelating agents |
| 01/22/2009 | WO2009012367A1 Composition and method of use for soft tissue augmentation/drug delivery |
| 01/22/2009 | WO2009012303A2 Therapeutic stable nanoparticles |
| 01/22/2009 | WO2009012268A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | WO2009012256A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | WO2009011367A1 Aqueous composition |
| 01/22/2009 | WO2009010967A1 An agent for treatment of inflammation |
| 01/22/2009 | WO2009010842A2 Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
| 01/22/2009 | WO2009010837A2 Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer |
| 01/22/2009 | WO2009010428A1 Protease stabilized, pegylated insulin analogues |
| 01/22/2009 | WO2009010296A2 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 01/22/2009 | WO2009010270A2 Purification of pegylated polypeptides |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2008116847A3 Material for the formation of structures having a support function |
| 01/22/2009 | WO2008087017A3 Novel cascade polymer complexes, method for their production and pharmaceutical agents containing the same |
| 01/22/2009 | WO2008079834A3 Preparation of paramagnetic nanoparticles conjugated to leukotriene b4 (ltb4) receptor antagonists, and their use as mri contrast agents for the detection of infection and inflammation |
| 01/22/2009 | WO2008035371A3 Dietary anti-bacterial compositions |
| 01/22/2009 | US20090024075 Method and Device for Treating Abnormal Tissue Growth With Electrical Therapy |
| 01/22/2009 | US20090024074 Electrochemically degradable polymers |
| 01/22/2009 | US20090023896 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/22/2009 | US20090023819 Use of an Artificial Sweetener to Enhance Absorption of Nicotine |
| 01/22/2009 | US20090023816 Process for making a solid compound by precipitation, suspensions of solid in liquids and solids obtained by the process and their use as additives |
| 01/22/2009 | US20090023690 Oral drug delivery system |
| 01/22/2009 | US20090023689 Oral drug delivery system |
| 01/22/2009 | US20090023678 Amino Acid Vitamin Ester Compositions for Controlled Delivery of Pharmaceutically Active Compounds |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023673 Lipid containing formulations |
| 01/22/2009 | US20090023635 Factor VII or VIIa - Like Molecules |
| 01/22/2009 | US20090023632 Hemoglobin-haptoglobin complexes |
| 01/22/2009 | US20090023160 Antibodies specific for CYP1B1 |
| 01/22/2009 | US20090022802 Cardiomyopathy therapeutic agent |
| 01/22/2009 | US20090022799 Compositions that contain beta-glucan to be used for the prevention and treatment of disease and methods for their use |
| 01/22/2009 | US20090022798 Formulations of nonopioid and confined opioid analgesics |
| 01/22/2009 | US20090022796 Novel Substituted Benzimidazole Dosage Forms and Method of Using Same |
| 01/22/2009 | US20090022790 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 01/22/2009 | US20090022766 Metal-enhanced fluorescence nanoparticles |
| 01/22/2009 | US20090022746 Complexes for transferring nucleic acids into cells |
| 01/22/2009 | US20090022701 Administering to the patient an amount of CLN2 protein (Neuronal ceroid lipofuscinoses (NCLs)) effective to reduce or eliminate the symptoms caused by the deficiencyl in CLN2 protein; Central nervous system disorders |
| 01/22/2009 | US20090022698 Composition For Treatment Of Articular Cartilage Damage |
| 01/22/2009 | US20090022683 Biodegradable and Thermosensitive Poly(Organophosphazene) Hydrogel, Preparation Method Thereof and Use Thereof |
| 01/22/2009 | US20090022679 Solid cosmetic composition |
| 01/22/2009 | US20090022669 Compositions for protein delivery via the pulmonary route |
| 01/22/2009 | US20090022658 Modified antibodies and methods of use |
| 01/22/2009 | CA2695952A1 Micro-particles, blood-substitute and method for forming same |
| 01/22/2009 | CA2694089A1 Therapeutic stable nanoparticles |
| 01/22/2009 | CA2693936A1 Conjugate purification |
| 01/22/2009 | CA2693255A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | CA2692912A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692826A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692823A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692819A1 Humanized anti-cd79b antibodies and immunoconjugates and methods of use |
| 01/22/2009 | CA2692612A1 Purification of pegylated polypeptides |
| 01/22/2009 | CA2691847A1 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/22/2009 | CA2691002A1 Self-assembling amphiphilic polymers as anticancer agents |
| 01/21/2009 | EP2017288A1 Protease stabilized, pegylated insulin analogues |
| 01/21/2009 | EP2017287A2 Method of producing hydroxyalkyl starch derivatives |
| 01/21/2009 | EP2017191A1 Edible film package having product for oral intake enclosed therein |
| 01/21/2009 | EP2016954A1 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 01/21/2009 | EP2016941A1 Transdermally absorbable donepezil preparation |
| 01/21/2009 | EP2016938A1 Preparation of submicron sized particles via dispersion and solevnt or liquid phase removal |
| 01/21/2009 | EP2016937A1 Formulation of liposomal vesicles in aqueous solutions with tear film characteristics |
| 01/21/2009 | EP2016935A1 Pharmaceutical composition for topical application of poorly soluble compounds |
| 01/21/2009 | EP2015795A1 Electrolyte solution and method for electrolytic co-deposition of thin film calcium phosphate and drug composites |
| 01/21/2009 | EP2015779A2 Transmucosal composition |
| 01/21/2009 | EP2015736A2 Spherical or non-sperical microcapsules comprising glp-1 peptides, their production and use |
| 01/21/2009 | EP2015730A1 Method for solubilising hydrophobic active substances in an aqueous medium |
| 01/21/2009 | EP1590004B1 Process for the production of improved thickened beverages for dysphagia |
| 01/21/2009 | EP1585770B1 Recognition molecules for the treatment and detection of tumours |
| 01/21/2009 | EP1560600B1 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
| 01/21/2009 | EP1513500B1 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with pradofloxacin and intrinsically viscous gelling agents as thickening agents |
| 01/21/2009 | EP1465491B1 Antiseptic compositions and methods |
| 01/21/2009 | EP1432443B1 Angiotensin peptide-carrier conjugates and uses thereof |
| 01/21/2009 | EP1353691B1 Molecular antigen array presenting amyloid beta |
| 01/21/2009 | EP1333036B1 Peg-modified erythropoietin |
| 01/21/2009 | EP1133316B1 Formulation of adenovirus for gene therapy |
| 01/21/2009 | EP1129209B1 Polymer grafting by polysaccharide synthases |
| 01/21/2009 | EP1053021B1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media |
| 01/21/2009 | EP1019438B1 Apoptosis-related compounds and their use |
| 01/21/2009 | EP0973507B1 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| 01/21/2009 | EP0850053B1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/21/2009 | EP0711127B2 Methods of preparing gas-filled liposomes |
| 01/21/2009 | CN101351227A Pharmaceutical composition for application to nail |
| 01/21/2009 | CN101351201A Pharmaceutical preparation of aqueous solution containing platinum complex |
| 01/21/2009 | CN101351190A Sodium chloride solution for drug reconstitution or dilution |
| 01/21/2009 | CN101348570A Preparation of star copolymer self-assembled nano micelle |
| 01/21/2009 | CN101348542A Emulsion polymerization process for industrial production of medicament coating material polyacrylic resin III |
| 01/21/2009 | CN101348524A Protein stabilization formulations |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/21/2009 | CN101347622A Oral liquid-crystal sustained-release composition and preparation |
| 01/21/2009 | CN101347614A Growth hormone formulations |
| 01/21/2009 | CN101347608A Chinese medicine soft capsules with cholagogic efficacy and preparation method thereof |
| 01/21/2009 | CN101347607A Ginger and magnolia bark valid target composition soft capsules and use thereof in medicine |
| 01/21/2009 | CN101347599A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and composition and preparation thereof |